---
figid: PMC6678221__cancers-11-00904-g001
figtitle: Role of the canonical Wnt/Beta-catenin pathway in cancer metabolism
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC6678221
filename: cancers-11-00904-g001.jpg
figlink: /pmc/articles/PMC6678221/figure/cancers-11-00904-f001/
number: F1
caption: Overview of the role of the canonical Wnt/β-catenin pathway in cancer metabolism.
  Activation of Wnt signaling requires the binding of Wnt glycoproteins to the frizzled
  (Fzd) receptor and the low-density lipoprotein receptor-related protein (LRP5/6)
  co-receptor. Receptor activation leads to the inhibition of the destruction complex,
  Axin2/APC/GSK3 through the recruitment of disheveled (Dvl). β-catenin can then accumulate
  in cytoplasm and translocate to the nucleus where the TCF/LEF family of transcriptional
  factors activate a wide range of Wnt target genes. Through c-MYC, Wnt controls the
  increased aerobic glycolysis, glutamine transporter ASCT2 levels and subsequent
  glutathione (GSH) production, which is implicated in cancer chemoresistance and
  cancer stem cell (CSC) survival via the inhibition of reactive oxygen species (ROS).
  Wnt also upregulates stearoyl-CoA desaturase-1 (SCD), in particular SCD1, which
  has been considered as the hallmark for CSC enrichment.
papertitle: Wnt Signaling in Cancer Metabolism and Immunity.
reftext: Sara El-Sahli, et al. Cancers (Basel). 2019 Jul;11(7):904.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9645342
figid_alias: PMC6678221__F1
figtype: Figure
redirect_from: /figures/PMC6678221__F1
ndex: 8be46145-ded2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6678221__cancers-11-00904-g001.html
  '@type': Dataset
  description: Overview of the role of the canonical Wnt/β-catenin pathway in cancer
    metabolism. Activation of Wnt signaling requires the binding of Wnt glycoproteins
    to the frizzled (Fzd) receptor and the low-density lipoprotein receptor-related
    protein (LRP5/6) co-receptor. Receptor activation leads to the inhibition of the
    destruction complex, Axin2/APC/GSK3 through the recruitment of disheveled (Dvl).
    β-catenin can then accumulate in cytoplasm and translocate to the nucleus where
    the TCF/LEF family of transcriptional factors activate a wide range of Wnt target
    genes. Through c-MYC, Wnt controls the increased aerobic glycolysis, glutamine
    transporter ASCT2 levels and subsequent glutathione (GSH) production, which is
    implicated in cancer chemoresistance and cancer stem cell (CSC) survival via the
    inhibition of reactive oxygen species (ROS). Wnt also upregulates stearoyl-CoA
    desaturase-1 (SCD), in particular SCD1, which has been considered as the hallmark
    for CSC enrichment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LRP6
  - LRP5
  - SLC1A5
  - AXIN1
  - AXIN2
  - GSK3A
  - GSK3B
  - ADAR
  - DVL1P1
  - APC
  - PROC
  - SCD
  - SCD5
  - CTNNB1
  - MYC
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - EP300
  - HNF4A
  - Lrp6
  - Lrp5
  - Slc1a5
  - Axin1
  - Gsk3b
  - Shh
  - Apc
  - Scd1
  - Ctnnb1
  - Myc
  - Nol3
  - Crebbp
  - Pag1
  - Cytip
  - Ep300
  - kita
  - ngfra
  - lrp6
  - lrp5
  - gsk3ba
  - gsk3ab
  - apc
  - scd
  - ctnnb1
  - myca
  - elk4
  - fz
  - arr
  - Axn
  - sgg
  - dsh
  - Apc2
  - Fs(3)Apc
  - arm
  - Hsc70-4
  - nej
  - CBP
  - eIF4E1
  - osa
  - pan
  - CsC
  - Lactate
  - Glucose
  - Glutamine
  - Glutathione
  - Cysteine
---
